Application note: Multiplexed automated imaging assay for cardiotoxic compounds using the ImageXpress Pico system
There is an increasing need to expand the variety and complexity of cell-based assays for biologic research and drug discovery.
Stem cell-derived cells and tissues have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. In this study, Molecular Devices scientists used human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to develop functional and morphological readouts for testing effects of different compounds in a multi-parametric assay format, using the ImageXpress Pico Automated Cell Imaging System.
Related content from this organisation
- Application note: Measure cancer cell viability using a homogeneous, stable luminescence assay
- eBook: Streamline beer, wine, and food quality control and safety analyses
- Application note: Detect endotoxin with the PyroGene Recombinant Factor C Assay
- Application note: Assess cell viability and proliferation with colorimetric readouts
- Application note: Streamline BCA-based protein quantitation on the SpectraMax iD5 reader